Pulmonary and disseminated tubercular disease by Bacillus of Calmette-Guérin after administration as a local adjuvant immunotherapy of relapsing bladder adenocarcinoma by Manfredi, Roberto & Dentale, Nicola
POSTER PRESENTATION Open Access
Pulmonary and disseminated tubercular disease
by Bacillus of Calmette-Guérin after
administration as a local adjuvant





th International Symposium on HIV and Emerging Infectious Diseases
Marseille, France. 24-26 March 2010
Background
Aim of our work is to present two exemplary cases of
patients (p) who received a prolonged intravesical
immunotherapy with instillations of Bacillus of Calm-
ette-Guérin (BCG), to treat an urothelial carcinoma of
the bladder relapsing after endoscopic-surgical treat-
ment, who suffered from a severe pulmonary infection
caused by Mycobacterium bovis. Their diagnostic path-
way was particularly cumbersome due to the co-existing
chronic pulmonary diseases (COPD), and prior respira-
tory disorders (including a juvenile tuberculosis). The
second presented p was also interested by a genito-urin-
ary (penile) localization of BCG infection, to attribute to
local BCG dissemination.
Methods
Both p (aged 77-58 years, respectively), had radiologi-
cal remnants of a prior tubercular infection, concur-
rently with a severe BPCO (at HRCT scan).
Histopathologic studies showed granulomatous-necro-
tizing lesions with a diffuse macrophage, histiocyte,
and giant cell infiltrate, followed by endoalveolar fbro-
sis in the second patient. No mycobacteria were
detected at microscopy-culture, as well as after poly-
merase chain reaction (PCR) assays.
Results
Our first p had a mild positive Mantoux intradermal
reaction while he tested frankly positive at the inter-
feron-gamma release assay (IGRA), thus representing
the first case of BCG-itis diagnosed also with the aid of
these recent techniques. From a clinical point of view,
the miliary-nodular-infiltrative picture of the first p, and
the granulomatous-fibrosing aspects of the second p,
showed a slow but progressive ameliorement during
anti-tubercolar therapy, but the long-term follow-up
detected a persisting worsening of respiratory function
parameters in the second p. When discussing the poten-
tial pathogenetic correlates between BCG intravesical
immunotherapy of bladder carcinoma and pulmonary
and lung-urogenital disease localizations, after careful
exclusion of other ethiologies we have no doubt in attri-
buting these complications to BCG, even in the absence
of bacterial isolation, just because the antigenic load
itself caused by repeated instillations of a live, attenu-
ated M. bovis strains (BCG) is a condition sufficient to
trigger a pulmonary and systemic disease, and drive its
subsequent evolution.
Discussion
To our knowledge, only four cases of respiratory BCG-
itis have been reported to date (as simil-tubercular
forms), two of them after periodical intravesical BCG
instillations, in p with relapsing urothelial cancer. The
second presented p represents the first case interested
by a dual, concurrent granulomatous BCG infections,
involving both genito-urinary and lower respiratory
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Internal Medicine, and Infectious Diseases specialists in
collecting the history and in monitoring patients who
undergo adjuvant BCG immunotherapy.
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